AstraZeneca has received a positive recommendation from the Committee for [...]

The National Institute for Health and Care Excellence (NICE) has [...]

Grifols’ Biotest has received its first regulatory approval for a [...]

The US Food and Drug Administration (FDA) has approved KOMZIFTI [...]

The Scottish Medicines Consortium (SMC) has accepted guselkumab for the [...]

Otsuka Pharmaceutical Europe has submitted a marketing authorisation application (MAA) [...]

Cidara Therapeutics has received Breakthrough Therapy designation from the US [...]

Phase 3 data for GSK’s depemokimab appear to support the [...]

AAVantgarde Bio has received two regulatory milestones for its investigational [...]

Proposed legislation aims to streamline biosimilar development and expand patient [...]